Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 100 /hr
Hire Susmita G.
United States
USD 100 /hr
Cancer Biologist with 10+ years of research experience | Scientific Writer | Research Consultant | Guest Reviewer (MDPI)
Profile Summary
Subject Matter Expertise
Services
Writing
Technical Writing,
General Proofreading & Editing
Research
Scientific and Technical Research,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Image Analysis,
Data Visualization
Work Experience
Research Investigator
The University of Texas MD Anderson Cancer Center
October 2023 - Present ![]()
Postdoctoral fellow
The University of Texas MD Anderson Cancer Center
November 2020 - October 2023 ![]()
Research Fellow
Ben-Gurion University (Beer Sheva, Israel)
March 2018 - April 2019
Education
Ph.D. in Science (Zoology)
University of Calcutta - Rajabazar Science College Campus
2013 - 2018 ![]()
M.Sc. (Zoology)
Presidency University
2010 - 2012 ![]()
B.Sc. (Honors) (Zoology)
South Calcutta Girls' College
2007 - 2010 ![]()
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Susmita Ghosh, Fan Fan, Reid T. Powell, Jason Roszik, Yong Sung Park, Clifford Stephan, Manu Sebastian, Lin Tan, Alexey V. Sorokin, Philip L. Lorenzi, et al. (2023). Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer . Molecular Cancer Therapeutics.
Susmita Ghosh, Fan Fan, Reid Powell, Jason Roszik, Yongsun Park, Mary Sobieski, Alexey Sorokin, Clifford Stephan, Scott Kopetz, Lee M. Ellis, et al.(2023). Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo . PLOS ONE. 18. (3). p. e0281063. Public Library of Science ({PLoS})
Fan, F., Ghosh, S., Powell, R., Roszik, J., Park, Y., Sobieski, M., Sorokin, A., Stephan, C., Kopetz, S., Ellis, L.M., et al.(2023). Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo . PLoS ONE. 18. (3 March).
Ghosh, S., Fan, F., Powell, R.T., Roszik, J., Park, Y.S., Stephan, C., Sebastian, M., Tan, L., Sorokin, A.V., Lorenzi, P.L., et al.(2023). Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer . Molecular Cancer Therapeutics. 22. (8). p. 962-975.
Susmita Ghosh (2022). Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments . Cancers.
Ghosh, Susmita, Fan, Fan, Roszik, Jason, Xia, Ling, Wang, Rui, Ye, Xiangcang, Hawke, David, Ellis, Lee M., Bhattacharya, Rajat (2022). Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments . Cancers.
Fan, F., Roszik, J., Xia, L., Ghosh, S., Wang, R., Ye, X., Hawke, D., Ellis, L.M., Bhattacharya, R.(2022). Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments . Cancers. 14. (8).
Susmita Ghosh (2021). Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity . Scientific reports.
Ghosh, Susmita, Ottolenghi, Aner, Bolel, Priyanka, Sarkar, Rhitajit, Greenshpan, Yariv, Iraqi, Muhammed, Bhattacharya, Baisali, Taylor, Zoe, V, Kundu, Kiran, Radinsky, Olga, et al. (2021). Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity . Scientific Reports.
Ottolenghi, A., Bolel, P., Sarkar, R., Greenshpan, Y., Iraqi, M., Ghosh, S., Bhattacharya, B., Taylor, Z.V., Kundu, K., Radinsky, O., et al.(2021). Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity . Scientific Reports. 11. (1).
Ghosh, Susmita, Fan, Fan, Ellis, Lee, Bhattacharya, Rajat (2021). Effects of chemotherapy on activation of the STING signaling pathway and enhancing immunotherapy responses in colorectal cancer . Cancer Research.
Susmita Ghosh (2019). Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA . Cancer immunology research.
Susmita Ghosh (2019). Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy . Frontiers in oncology.
Ghosh, Susmita, Prasad, Manu, Kundu, Kiran, Cohen, Limor, Yegodayev, Ksenia M., Zorea, Jonathan, Joshua, Ben-Zion, Lasry, Batel, Dimitstein, Orr, Bahat-Dinur, Anat, et al. (2019). Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy . Frontiers in Oncology.
Ghosh, S., Prasad, M., Kundu, K., Cohen, L., Yegodayev, K.M., Zorea, J., Joshua, B.-Z., Lasry, B., Dimitstein, O., Bahat-Dinur, A., et al.(2019). Tumor tissue explant culture of patient-derived xenograft as potential prioritization tool for targeted therapy . Frontiers in Oncology. 9. (JAN).
Ghosh, Susmita, Kundu, Kiran, Sarkar, Rhitajit, Edri, Avishay, Brusilovsky, Michael, Gershoni-Yahalom, Orly, Yossef, Rami, Shemesh, Avishai, Soria, Jean-Charles, Lazar, Vladimir, et al. (2019). Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA . Cancer Immunology Research.
Kundu, K., Ghosh, S., Sarkar, R., Edri, A., Brusilovsky, M., Gershoni-Yahalom, O., Yossef, R., Shemesh, A., Soria, J.-C., Lazar, V., et al.(2019). Inhibition of the NKp44-PCNA immune checkpoint using a MAb to PCNA . Cancer Immunology Research. 7. (7). p. 1120-1134.
Susmita Ghosh (2018). IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer . Cell death & disease.
Susmita Ghosh (2018). NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death . Frontiers in immunology.
Ghosh, Susmita, Shemesh, Avishai, Kundu, Kiran, Peleg, Refael, Yossef, Rami, Kaplanov, Irena, Khrapunsky, Yana, Gershoni-Yahalom, Orly, Rabinski, Tatiana, Cerwenka, Adelheid, et al. (2018). NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death . Frontiers in Immunology.
Shemesh, A., Kundu, K., Peleg, R., Yossef, R., Kaplanov, I., Ghosh, S., Khrapunsky, Y., Gershoni-Yahalom, O., Rabinski, T., Cerwenka, A., et al.(2018). NKp44-derived peptide binds proliferating cell nuclear antigen and mediates tumor cell death . Frontiers in Immunology. 9. (MAY).
Ghosh, S., Elkabets, M., Kundu, K., Roisman, L., Levitas, D., Porgador, A., Peled, N. (2018). Ex Vivo 2(star)2(star)2 Tumor Tissue Explant Culture for Precision Medicine in Immunotherapy and TKI progressors in Lung Cancer . Journal of Thoracic Oncology.
Ghosh, Susmita, Zorea, Jonatan, Prasad, Manu, Cohen, Limor, Li, Nan, Schefzik, Roman, Rotblat, Barak, Brors, Benedikt, Elkabets, Moshe (2018). IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in <i>PIK3CA</i>-driven ovarian cancer . Cell Death and Disease.
Zorea, J., Prasad, M., Cohen, L., Li, N., Schefzik, R., Ghosh, S., Rotblat, B., Brors, B., Elkabets, M.(2018). IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer . Cell Death and Disease. 9. (10).
Susmita Ghosh (2016). Anti-osteoarthritic activity of Bungarus fasciatus venom fraction BF-F47 involving molecular markers in the rats . Toxicon : official journal of the International Society on Toxinology.
Ghosh, Susmita, Gomes, Antony, Ghosh, Sourav, SahaA, Ialyani, Saha, Partha Pratim, Dasgupta, Subir Chandra, Gomes, Aparna (2016). Anti-osteoarthritic activity of Bungarus fasciatus venom fraction BF-F47 involving molecular markers in the rats . Toxicon.
Gomes, A., Ghosh, S., Ghosh, S., Saha, K., Saha, P.P., Dasgupta, S.C., Gomes, A.(2016). Anti-osteoarthritic activity of Bungarus fasciatus venom fraction BF-F47 involving molecular markers in the rats . Toxicon. 118. p. 43-46.
Ghosh, S., Saha, P.P., Dasgupta, S.C., Gomes, A.(2016). Antinociceptive, anti-inflammatory and antiarthritic activities of Bungarus fasciatus venom in experimental animal models . Indian Journal of Experimental Biology. 54. (9). p. 569-576.